| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/26/2009 | EP2091556A2 G protein coupled receptors and uses thereof |
| 08/26/2009 | EP2091555A1 Use of il-27 agonists to reduce immune mediated abortion |
| 08/26/2009 | EP2091553A2 Casein-derived peptides having anxiolytic activity |
| 08/26/2009 | EP2091552A2 Stabilized maml peptides and uses thereof |
| 08/26/2009 | EP2091551A2 Method of diagnosing and treating asthma |
| 08/26/2009 | EP2091550A2 Methods of promoting cardiac repair using growth factors fused to heparin binding sequences |
| 08/26/2009 | EP2091516A2 Peptide nanoparticles and uses therefor |
| 08/26/2009 | EP2091513A2 Ejection liquid and ejection method |
| 08/26/2009 | EP2091353A1 Treatment of ectoparasitic infestation |
| 08/26/2009 | EP2091352A2 Animal feeds and veterinary compositions |
| 08/26/2009 | EP2004633A4 Linear natriuretic peptide constructs |
| 08/26/2009 | EP1888096A4 Milk fat globule epidermal growth factor-factor viii and sepsis |
| 08/26/2009 | EP1877072A4 Bone cement compositions and the like comprising an rnaiii-inhibiting peptide |
| 08/26/2009 | EP1796694A4 Methods to enhance hemodynamic stability using oxygen carrying compositions |
| 08/26/2009 | EP1776134A4 C-met kinase binding proteins |
| 08/26/2009 | EP1711200A4 Type ii diabetes |
| 08/26/2009 | EP1694705B1 Interleukin-10 antibodies |
| 08/26/2009 | EP1648481B1 Viral vectors |
| 08/26/2009 | EP1625153B1 Acylated lysobactin-type nonadepsipeptides |
| 08/26/2009 | EP1624885A4 Synthetic peptide analogs of arg-pro-pro-gly-phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 |
| 08/26/2009 | EP1601694B1 Uses of il-23 antagonists; related reagents |
| 08/26/2009 | EP1585537A4 1-desamino-8-d-arginyl vasopressin analogs |
| 08/26/2009 | EP1537875B1 C-terminal globular domain of adiponectin for use in the treatment of arteriosclerosis |
| 08/26/2009 | EP1530584B1 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 08/26/2009 | EP1503780B1 Androgen-regulated pmepa1 gene and methods of using the same to inhibit cancer cell growth |
| 08/26/2009 | EP1496929A4 Use of c5a receptor antagonist in the treatment of fibrosis |
| 08/26/2009 | EP1478328A4 Bioactive keratin peptides |
| 08/26/2009 | EP1450855B1 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof |
| 08/26/2009 | EP1423428B1 Antibodies that block fgfr3 activation, methods of screening for and uses thereof |
| 08/26/2009 | EP1379698B1 Mobility-modified nucleobase polymers and methods of using same |
| 08/26/2009 | EP1297005B1 Immunisation against chlamydia pneumoniae |
| 08/26/2009 | EP1283675A4 Methods of modulating the activity of mura |
| 08/26/2009 | EP1237915B1 Polynucleotid encoding the rg1 polypeptide |
| 08/26/2009 | EP1147212B1 T helper cell epitopes |
| 08/26/2009 | EP1082908B1 Additives for crustacean or fish feeds and feeds |
| 08/26/2009 | EP1012187B1 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response |
| 08/26/2009 | EP1007700B1 Monoclonal antibody against a prion protein and its use for the detection of prions |
| 08/26/2009 | CN101517414A Stimulatory auto-antibodies to the PDGF receptor as pathology marker and therapeutic target |
| 08/26/2009 | CN101517407A An animal model for studying atherosclerotic lesions |
| 08/26/2009 | CN101517078A Methods of diagnosing and treating complications of pregnancy |
| 08/26/2009 | CN101516969A Targeted polylysine dendrimer therapeutic agent |
| 08/26/2009 | CN101516909A CD4-receptor-derived peptides and method for the preparation thereof |
| 08/26/2009 | CN101516902A Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia |
| 08/26/2009 | CN101516402A Gel type enteric nutrient |
| 08/26/2009 | CN101516400A Therapeutic agent for acceleration of spinal nerve repair comprising ghrelin, derivative thereof or substance capable of acting on GHS-R1a as active ingredient |
| 08/26/2009 | CN101516399A Therapeutic agent for acceleration of spinal nerve repair comprising desacyl ghrelin or derivative thereof as active ingredient |
| 08/26/2009 | CN101516392A Long-lasting absorption of flavonoids |
| 08/26/2009 | CN101516391A Methods for administering long-lasting hypoglycemic agents |
| 08/26/2009 | CN101516390A Agent for preventing development of reflex sympathetic dystrophy after stroke |
| 08/26/2009 | CN101516389A Combination therapy for treatment of viral infections |
| 08/26/2009 | CN101516388A Glycosylation of peptides via O-linked glycosylation sequences |
| 08/26/2009 | CN101516387A Caspofungin formulations |
| 08/26/2009 | CN101516382A Cationic latex as a carrier for bioactive ingredients and methods for making and using the same |
| 08/26/2009 | CN101516375A Combinations of class-I specific histone deacetylase inhibitors with proteasome inhibitors |
| 08/26/2009 | CN101516374A Histone deacetylase inhibitors with combined activity on class-I and class-IIB histone deacetylases in combination with proteasome inhibitors |
| 08/26/2009 | CN101516362A Polymeric conjugates containing positively-charged moieties |
| 08/26/2009 | CN101514355A Method for preparing wheat germ protein ACE inhibitory peptide by continuous enzymolysis and ultra-filtration separation coupling |
| 08/26/2009 | CN101514354A Sea cucumber polypeptide, preparation method and application thereof |
| 08/26/2009 | CN101514335A Expression and purification of influenza virus polymerase PA and crystal structure of complex of polypeptides at amino terminal of PA, carboxyl terminal of PA and amino terminal of PB1 |
| 08/26/2009 | CN101514232A RANKL-Fc fusion protein, preparation method and application thereof |
| 08/26/2009 | CN101514231A Fusion protein for resisting formation of thrombus targetedly and preparation method and application thereof |
| 08/26/2009 | CN101514229A Human interferon alpha derivative and polyethylene glycol modified substance thereof |
| 08/26/2009 | CN101514228A N-terminal modified human thymosin alfa 1 compound and preparation method thereof |
| 08/26/2009 | CN101514225A Self-polymerization polypeptide and preparation method and application thereof |
| 08/26/2009 | CN101514223A Method for preparation of site-specific protein conjugates |
| 08/26/2009 | CN101513529A W/O type micro emulsion carrier for insulin injection and preparation method thereof |
| 08/26/2009 | CN101513525A Application of collagen and pharmaceutical compositions thereof in gynecology |
| 08/26/2009 | CN101513524A Alpha-interferon dry powder inhalant for pigs and method for producing same |
| 08/26/2009 | CN101513523A Medicine containing cell polypeptide growth factor and preparation method thereof |
| 08/26/2009 | CN101513407A Application of naloxone and composition thereof in preparing drug for treating cancer |
| 08/26/2009 | CN101513395A Taxol double-layer soft capsule oral preparation medicament |
| 08/26/2009 | CN101513390A Hydrochloric acid boanmycin liposomes and preparation method thereof |
| 08/26/2009 | CN100532563C Pharmaceutical product comprising tissue of the male vegetal reproductive system |
| 08/26/2009 | CN100532549C Genes and polypeptides relating to human colon cancers |
| 08/26/2009 | CN100532392C Reductive alkylation process |
| 08/26/2009 | CN100531889C Process for producing coated fine particle |
| 08/26/2009 | CN100531798C Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody |
| 08/26/2009 | CN100531797C Novel use of erythropoietin in heart diseases |
| 08/26/2009 | CN100531796C FGFR agonists |
| 08/26/2009 | CN100531795C Omega-conotoxin M VII A mutant and its preparation and uses |
| 08/26/2009 | CN100531794C Compositions and methods for modifying toxic effects of protein compounds |
| 08/25/2009 | USRE40882 High concentration of alpha, beta or gamma interferon in buffered solution with polyvinylpyrrolidone and/or polyethylene oxide, and antioxidant, Trilon B (disodium salt of ethylenediaminetetraacetic acid); bioavailability; topical administration to mucous membrane with prolonged contact; bioavailability |
| 08/25/2009 | US7579455 Antisense agents against genes coding for phosphodiesterase; for treatment of asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome, bronchitis, chronic bronchitis, silicosis, pulmonary fibrosis, lung allograft rejection, allergic rhinitis and chronic sinusitis |
| 08/25/2009 | US7579447 Antibodies against LLG polypeptides of the triacylglycerol lipase family |
| 08/25/2009 | US7579442 Spraying solution of collagen onto conductive target from needle maintained at high electrical potential; evaporation of solvent; implanting scaffold during laser corneal ablation |
| 08/25/2009 | US7579441 Interleukins; immunoglobulins; for stimulating proliferation and/or development of hematopoietic cells in vitro and in vivo |
| 08/25/2009 | US7579439 Modulation of IL-2- and IL-15-mediated T cell responses |
| 08/25/2009 | US7579437 Polypeptides and methods for making the same |
| 08/25/2009 | US7579435 Somatostatin-dopamine chimeric analogs |
| 08/25/2009 | US7579434 Peptide having ability to activate cancer-related gene |
| 08/25/2009 | US7579433 18-Residue dimerized peptide designated PIP [59-67] dimer, having dual inhibitory activity against secretory phospholipase A2 (sPLA2) and matrix metalloproteinases (MMPs); acute pancreatitis; infection; neurodegenerative disease; neuronal excitotoxicity |
| 08/25/2009 | US7579432 Cyclic peptides as G-protein-coupled receptor antagonists |
| 08/25/2009 | US7579330 Methods of treating various cancers using melanoma differentiation associated protein-7 |
| 08/25/2009 | US7579326 Gene switch systems employing regulators with decreased dimerization |
| 08/25/2009 | US7579323 Analogs of hemiasterlin wherein the indole moiety of hemiasterlin has been deleted or replaced demonstrate potent anti-mitotic and cytotoxic activity; may be useful in treatment of colon, breast, lung cancers |
| 08/25/2009 | US7579322 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 08/25/2009 | US7579321 Incotinence therapy controlling dosage |
| 08/25/2009 | US7579320 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents |
| 08/25/2009 | US7579319 Administering to a human having thickened arterioles in brain, kidney or alveoli a peptide that ranges in length up to 30 amino acids, and that comprises a class A amphipathic helix, and bears at least one protecting group |
| 08/25/2009 | US7579318 Cell penetrating peptides for intracellular delivery of molecules |